Literature DB >> 1998521

Specific binding of vascular permeability factor to endothelial cells.

J V Olander1, D T Connolly, J E DeLarco.   

Abstract

Vascular permeability factor (VPF), also known as vascular endothelial cell growth factor, has recently been purified from guinea pig, human, and bovine sources. We show that various fetal or adult endothelial cell strains originating from either capillary or large vessels possess specific high affinity and saturable binding sites for guinea pig tumor-derived [125I]VPF. Two classes of sites with KDs of approximately 10 pM and 1 nM were detected for all endothelial cell types examined. Guinea pig [125I]VPF binding to endothelial cells was inhibited by human VPF (ID50 = 0.8 ng/ml) and by suramin (ID50 = 75 micrograms/ml) but not by heparin. Cross-linking experiments revealed specific [125I]VPF-receptor complexes of two types. Most of the complexes migrated very slowing in SDS-PAGE, indicating that they were of very high molecular weight and probably highly cross-linked. A portion of the molecules migrated as 270 kDa complexes, indicating that the molecular weight of the endothelial cell VPF receptor is about 230 kDa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998521     DOI: 10.1016/s0006-291x(05)81201-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Authors:  John Doukas; Wolfgang Wrasidlo; Glenn Noronha; Elena Dneprovskaia; Richard Fine; Sara Weis; John Hood; Anthony Demaria; Richard Soll; David Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

2.  Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Authors:  Traci A Wilgus; Annette M Matthies; Katherine A Radek; Julia V Dovi; Aime L Burns; Ravi Shankar; Luisa A DiPietro
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.

Authors:  M Berard; S Sordello; N Ortega; J L Carrier; N Peyri; M Wassef; N Bertrand; O Enjolras; L Drouet; J Plouet
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.

Authors:  P D Collins; D T Connolly; T J Williams
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

5.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

Authors:  G D'Angelo; I Struman; J Martial; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

6.  Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.

Authors:  N N Nissen; P J Polverini; A E Koch; M V Volin; R L Gamelli; L A DiPietro
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

7.  HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.

Authors:  Tong-Young Lee; Judah Folkman; Kashi Javaherian
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.

Authors:  T P Quinn; K G Peters; C De Vries; N Ferrara; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Vascular endothelial growth factor and the collateral circulation: the story continues.

Authors:  William M Chilian; Yuh Fen Pung
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 10.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.